The effect of losartan on left ventricularhypertrophy induced by primary hypertension:with 56 cases report
Chuan Zhang
Abstract
Chuan Zhang
Abstract
Objective: To observe the effect of angiotensionⅡ receptor antagonist Losartan on left ventricular hypertrophy(LVH) in primary hypertensive patients. Method: 56 cases of primary hypertension with LVH received Losartan(50mg,q.d.) for 4 months. Results: The total antihypertensive effective rate of Losartna was 90% . At the same time,Losartan reduced left ventricular wall thickness,left vintricular mass weight,left ventricular mass weight index and A/E(P0. 01). Conclusion: Treatment with Losartan for 4 months may induce LVH regression,improve diastolic function. No severe side effects were found.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the effect of angiotensionⅡ receptor antagonist Losartan on left ventricular hypertrophy(LVH) in primary hypertensive patients. Method: 56 cases of primary hypertension with LVH received Losartan(50mg,q.d.) for 4 months. Results: The total antihypertensive effective rate of Losartna was 90% . At the same time,Losartan reduced left ventricular wall thickness,left vintricular mass weight,left ventricular mass weight index and A/E(P0. 01). Conclusion: Treatment with Losartan for 4 months may induce LVH regression,improve diastolic function. No severe side effects were found.
Key concepts: Losartan, Left ventricular hypertrophy, Medicine, Angiotensin II receptor antagonist, Cardiology, Internal medicine, Antagonist, Muscle hypertrophy